-
1
-
-
0024517127
-
Methotrexate induces clinical and histological remission in patients with refractory inflammatory bowel disease
-
R.A. Kozarek D.J. Patterson M.D. Gelfand Methotrexate induces clinical and histological remission in patients with refractory inflammatory bowel disease Ann Intern Med 110 1989 353 356
-
(1989)
Ann Intern Med
, vol.110
, pp. 353-356
-
-
Kozarek, R.A.1
Patterson, D.J.2
Gelfand, M.D.3
-
2
-
-
0028899859
-
Methotrexate for the treatment of Crohn’s disease
-
B.G. Feagan J. Ronchon R.N. Fedorak Methotrexate for the treatment of Crohn’s disease N Engl J Med 332 1995 292 297
-
(1995)
N Engl J Med
, vol.332
, pp. 292-297
-
-
Feagan, B.G.1
Ronchon, J.2
Fedorak, R.N.3
-
3
-
-
0030069646
-
Methotrexate for inflammatory bowel disease: Pharmacology and preliminary results
-
L.J. Egan W.J. Sandborn Methotrexate for inflammatory bowel disease Pharmacology and preliminary results Mayo Clin Proc 71 1996 69 86
-
(1996)
Mayo Clin Proc
, vol.71
, pp. 69-86
-
-
Egan, L.J.1
Sandborn, W.J.2
-
5
-
-
0029923360
-
A review of immune modifier therapy for inflammatory bowel disease: Azathioprine, 6-mercaptopurine, cyclosporine, and methotrexate
-
W.J. Sandborn A review of immune modifier therapy for inflammatory bowel disease Azathioprine, 6-mercaptopurine, cyclosporine, and methotrexate Am J Gastroenterol 91 1996 423 433
-
(1996)
Am J Gastroenterol
, vol.91
, pp. 423-433
-
-
Sandborn, W.J.1
-
6
-
-
0032913394
-
Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn’s disease: A European multicenter trial
-
S.G. D’Haen S. Van Deventer R. Van Hogezand Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn’s disease A European multicenter trial Gastroenterology 116 1999 1029 1034
-
(1999)
Gastroenterology
, vol.116
, pp. 1029-1034
-
-
D’Haen, S.G.1
Van Deventer, S.2
Van Hogezand, R.3
-
7
-
-
0343081012
-
Methotrexate in Crohn’s disease: Long-term efficacy and toxicity
-
M. Lémann T. Zenjari Y. Bouhnik Methotrexate in Crohn’s disease Long-term efficacy and toxicity Am J Gastroenterol 95 2000 1730 1734
-
(2000)
Am J Gastroenterol
, vol.95
, pp. 1730-1734
-
-
Lémann, M.1
Zenjari, T.2
Bouhnik, Y.3
-
9
-
-
0018888679
-
Treatment of Crohn’s disease with 6-mercaptopurine. A long-term, randomized, double-blind study
-
D.H. Present B.L. Korelitz N. Wisch Treatment of Crohn’s disease with 6-mercaptopurine. A long-term, randomized, double-blind study N Engl J Med 302 1980 981 987
-
(1980)
N Engl J Med
, vol.302
, pp. 981-987
-
-
Present, D.H.1
Korelitz, B.L.2
Wisch, N.3
-
10
-
-
0030041584
-
Long-term follow-up of patients with Crohn’s disease treated with azathioprine or 6-mercaptopurine
-
Y. Bouhnik M. Lémann J.-Y. Marg Long-term follow-up of patients with Crohn’s disease treated with azathioprine or 6-mercaptopurine Lancet 347 1996 215 219
-
(1996)
Lancet
, vol.347
, pp. 215-219
-
-
Bouhnik, Y.1
Lémann, M.2
Marg, J.-Y.3
-
11
-
-
0007397087
-
Does chronic methotrexate cause liver toxicity when used for refractory inflammatory bowel disease?
-
R.A. Kozarek J.E. Bredfeldt L.E. Rosoff Does chronic methotrexate cause liver toxicity when used for refractory inflammatory bowel disease? Gastroenterology 100 1991 A221
-
(1991)
Gastroenterology
, vol.100
, pp. A221
-
-
Kozarek, R.A.1
Bredfeldt, J.E.2
Rosoff, L.E.3
-
12
-
-
0027340085
-
Immunosuppressive therapy for inflammatory bowel disease
-
R.A. Kozarek Immunosuppressive therapy for inflammatory bowel disease Aliment Pharmacol Ther 7 1993 117 123
-
(1993)
Aliment Pharmacol Ther
, vol.7
, pp. 117-123
-
-
Kozarek, R.A.1
|